GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharnext SA (XPAR:ALPHA) » Definitions » Additional Paid-In Capital

Pharnext (XPAR:ALPHA) Additional Paid-In Capital : €5.81 Mil(As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Pharnext Additional Paid-In Capital?


Pharnext's quarterly additional paid-in capital increased from Dec. 2022 (€7.23 Mil) to Jun. 2023 (€15.10 Mil) but then stayed the same from Jun. 2023 (€15.10 Mil) to Dec. 2023 (€5.81 Mil).

Pharnext's annual additional paid-in capital declined from Dec. 2021 (€136.65 Mil) to Dec. 2022 (€7.23 Mil) and declined from Dec. 2022 (€7.23 Mil) to Dec. 2023 (€5.81 Mil).


Pharnext Additional Paid-In Capital Historical Data

The historical data trend for Pharnext's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharnext Additional Paid-In Capital Chart

Pharnext Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 99.30 113.85 136.65 7.23 5.81

Pharnext Semi-Annual Data
Dec13 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 136.65 14.25 7.23 15.10 5.81

Pharnext Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Pharnext Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Pharnext's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharnext (XPAR:ALPHA) Business Description

Industry
Traded in Other Exchanges
Address
11-13 Rue Rene Jacques, Issy-Les-Moulineaux, FRA, 92130
Pharnext SA is a biopharmaceutical company developing treatments targeting neurodegenerative diseases. The company also develop a Pleotherapy technology platform. Its product in the pipeline includes SYNGILITY; PXT3003 and PXT864. The company's only segment being research and development on new pharmaceutical therapies based on Pleotherapy.

Pharnext (XPAR:ALPHA) Headlines

No Headlines